Deren Huang
Neurology · Newark, OHNPI 1841461019
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Biogen accounts for 66.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $31,254 and has fallen 99.9% since, to $16 in 2024.
Across 136 payments — averaging $390.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$35K
- Genentech USA, Inc.$6K
- Bristol Myers Squibb$6K
- Novartis$3K
- Eisai Inc.$2K
- AstraZeneca$145
- plus $528 from 16 others
Across 377 payments — averaging $12,299 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.4M
- Eisai Inc.$838K
- F. Hoffmann-la Roche AG$518K
- Sanofi$507K
- Genentech, Inc.$167K
- Bristol Myers Squibb$100K
- plus $125K from 7 others
What the payments were for
- Consulting fees$14,14527%
- Speaking & faculty fees$31,25059%
- Travel & lodging$4,1208%
- Food & beverage$3,3636%
- Education$2010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 37 | $35,073 |
| Genentech USA, Inc. | 11 | $6,275 |
| Bristol Myers Squibb | 13 | $6,139 |
| Novartis | 22 | $2,936 |
| Eisai Inc. | 17 | $1,984 |
| AstraZeneca | 4 | $145 |
| EMD Serono, Inc. | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| CSL Behring | 3 | $58 |
| Abbott | 1 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Avanir Pharmaceuticals, Inc. | 2 | $36 |
| Amgen(2 entities) | 2 | $34 |
| Sanofi | 2 | $30 |
| Tanabe Pharma America, Inc. | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Vertical Pharmaceuticals, LLC | 2 | $23 |
| GE HealthCare | 2 | $17 |
| AbbVie | 1 | $15 |
| Promius Pharma LLC | 1 | $13 |
| MDD US Operations, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$53,079 in reported general payments places this provider in the 85th percentile of 702 neurology providers in Ohio.
Other neurology in Newark
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Lawrence ElmerToledo$687K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
- Geoffrey EubankColumbus$508K
- Lawrence GoldstickDayton$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.